What Boards Should Do
Blue Ribbon Commission
Strategy Execution Oversight Diagnostic
Implement Recommendation 7 from the NACD's 2026 Blue Ribbon Commission report: Diagnose when signals suggest a strategic inflection point.
How to use this tool: Board chairs and lead independent directors can use this diagnostic as an analytical tool to support discussions about the status of strategy execution, particularly when directors differ in their assessments. The diagnostic helps boards develop a shared interpretation of strategy execution signals and consider when the board needs to adjust its engagement with management.
One challenge for directors is determining when to lean in more deeply on strategy execution progress without becoming overly involved in the company’s day-to-day operations. Other key considerations include avoiding underreacting to ongoing shifts, overreacting to routine or minor variations, and misreading changes in strategy execution. A simplified diagnostic can help directors develop a shared view of when internal and external signals may prompt an adjustment in board engagement.
Thank you for your interest in this page.